Revenue from continuing operations stood at Rs 1,634.65 crore in the quarter under review. It was Rs 1,156.07 crore in the same period a year ago, it added.from Stocks-Markets-Economic Times https://ift.tt/3iIKcjG
Jubilant Pharmova Q1 results: Co posts net profit of Rs 160 crore
Revenue from continuing operations stood at Rs 1,634.65 crore in the quarter under review. It was Rs 1,156.07 crore in the same period a year ago, it added.from Stocks-Markets-Economic Times https://ift.tt/3iIKcjG
Related Posts:
Videocon case: Sebi slaps Rs 75 lakh fine on Venugopal Dhoot, two entities- Standard Life to sell 5% stake in HDFC AMC on Wednesday
- Two major block deals worth Rs 6,017 crore were executed on Wednesday
- Sebi confirms ban on 5 persons in Zee insider trading case
- Acuite Ratings joins hands with United Nations for ESG in a first
0 Comments:
Post a Comment